Analyst Price Targets — SF
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 23, 2026 1:39 pm | — | UBS | $90.00 | $80.19 | TheFly | Stifel Financial price target raised to $90 from $86 at UBS |
| July 8, 2026 12:42 pm | Michael Brown | UBS | $86.00 | $73.42 | TheFly | Stifel Financial price target lowered to $86 from $89 at UBS |
| April 8, 2026 12:28 pm | — | UBS | $89.00 | $76.92 | TheFly | Stifel Financial price target lowered to $89 from $100 at UBS |
| January 14, 2026 10:34 am | — | Stifel Nicolaus | $92.00 | $86.13 | TheFly | Stifel Financial downgraded to Hold from Buy at TD Cowen |
| January 7, 2026 4:07 pm | Steven Chubak | Wolfe Research | $99.33 | $86.89 | TheFly | Stifel Financial price target raised to $149 from $142 at Wolfe Research |
| December 11, 2025 5:30 am | Michael Brown | UBS | $100.00 | $86.66 | StreetInsider | UBS Assumes Stifel Financial (SF) at Buy |
| October 9, 2025 9:53 am | — | UBS | $90.00 | $74.49 | TheFly | Stifel Financial price target raised to $135 from $130 at Citizens JMP |
| October 8, 2025 9:33 am | — | Stifel Nicolaus | $87.33 | $73.99 | TheFly | Stifel Financial upgraded to Buy from Hold at TD Cowen |
| July 31, 2025 9:33 am | — | Stifel Nicolaus | $90.00 | $76.74 | TheFly | Stifel Financial upgraded to Buy from Neutral at Citi |
| October 24, 2024 6:31 am | Michael Brown | Wells Fargo | $75.33 | $67.48 | TheFly | Stifel Financial price target raised to $113 from $108 at Wells Fargo |
Latest News for SF
Canada Pension Plan Investment Board purchased a new position in Stifel Financial Corporation (NYSE: SF) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 93,950 shares of the financial services provider's stock, valued at approximately $6,555,000. Canada Pension Plan Investment Board
ST. LOUIS, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for July 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.
Stifel has reiterated its 'buy' rating on Faron Pharmaceuticals Limited (AIM:FARN), the Finnish biotech, maintaining a price target of €2.50 after the company's interims, which showed the company well-funded to push on with value-accretive work in the clinic. The stock closed at €0.48 on 25 August, implying upside of 418.1% to the target price.
Bank of New York Mellon Corp acquired a new stake in Stifel Financial Corporation (NYSE: SF) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,336,318 shares of the financial services provider's stock, valued at approximately $93,235,000. Bank of New York Mellon Corp
Bank of Nova Scotia acquired a new stake in Stifel Financial Corporation (NYSE: SF) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 519,811 shares of the financial services provider's stock, valued at approximately $36,267,000. Bank of Nova Scotia owned 0.34%
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SF.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.